Introducing Winter 2022 Breakthroughs

 Michael B. Kastan, MD, PhDWhat if fewer people developed cancer? After all, cancer prevention is the ultimate therapy. That’s the vision that we are working toward with our new Cancer Risk, Detection, and Interception Research Program. In this issue you’ll read about this multidisciplinary group of doctors and scientists who are working together to make that vision a reality.

You will also read about an example of how the collaborative environment and wide-ranging expertise at Duke makes it the perfect place to translate findings from the laboratory to the clinic. In this case it is a test that shows promise for diagnosing pancreatic cancer in its early stages, when it is much more treatable. As always, you will see the faces of just a few of our remarkable donors and friends who are partnering with us every day to raise awareness of and support for people with cancer and cancer research.

Thank you for all you do for Duke Cancer Institute. None of our efforts to discover, develop, and deliver the future of cancer care now would be possible without you.

Michael Kastan signature

Michael B. Kastan, MD, PhD
Executive Director, Duke Cancer Institute
William and Jane Shingleton Professor of Pharmacology and Cancer Biology
Professor of Pediatrics